{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-303190","form_type":"8-K","ticker":"JAGX","cik":"0001585608","company_name":"Jaguar Health, Inc.","filed_at":"2026-07-14T20:15:12+00:00","discovered_at":"2026-07-14T20:16:00.408914+00:00","generated_at":"2026-07-14T20:16:16.051584+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Jaguar Health subsidiary Napo enters new 3-year manufacturing agreement with Alivus for crofelemer supply","bullets":["New agreement with Alivus Life Sciences for manufacture of crofelemer for Mytesi and other products.","Term from July 9, 2026 to March 31, 2029; replaces prior agreement that expired March 31, 2026.","Includes minimum purchase quantities; shortfall payment obligation if not met.","May be terminated for any reason with 12 months' notice, or for material breach with 90-day cure.","In insolvency, rights assigned to Woodward Specialty LLC (affiliate of Future Pak)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-303190","json":"https://secwatch.observer/filing/0001193125-26-303190.json","markdown":"https://secwatch.observer/filing/0001193125-26-303190.md","text":"https://secwatch.observer/filing/0001193125-26-303190.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526303190/0001193125-26-303190-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526303190/d144017d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-14T20:16:16.051584+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}